Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Noha H. Sayed, Nevine Fathy, Mona A. Kortam, et al.
Neurotherapeutics (2019) Vol. 17, Iss. 1, pp. 252-268
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 683
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 28
Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways
Tian Jin, Yong Zhang, Benson O. A. Botchway, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113091-113091
Closed Access | Times Cited: 65
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Sonalika Bhalla, Sidharth Mehan, Andleeb Khan, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 142, pp. 104896-104896
Closed Access | Times Cited: 62
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids
Leila Kooshki, Seyede Nazanin Zarneshan, Sajad Fakhri, et al.
Phytomedicine (2023) Vol. 112, pp. 154686-154686
Closed Access | Times Cited: 35
Modulation of p38 MAPK and Nrf2/HO-1/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of Clemastine in EAE rat model
Tarek K. Motawi, Shohda A. El‐Maraghy, Ahmed S. Kamel, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115435-115435
Closed Access | Times Cited: 25
DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 923-936
Closed Access | Times Cited: 23
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
Seong‐Jin Yu, Yun Wang, Hui Shen, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4349-4371
Open Access | Times Cited: 10
Brain-Derived Neurotrophic Factor (BDNF) in Huntington’s Disease: Neurobiology and Therapeutic Potential
Khairunnuur Fairuz Azman, Rahimah Zakaria
Current Neuropharmacology (2025) Vol. 23, Iss. 4, pp. 384-403
Closed Access | Times Cited: 1
Unveiling Acid-Sensing Ion Channels (ASICs) in Neurodegeneration: Implications for Disease Pathogenesis and Therapeutic Strategies
Maneesh Mohan, Ashi Mannan, Thakur Gurjeet Singh
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1
Signaling Pathways in Oxidative Stress-Induced Neurodegenerative Diseases: A Review of Phytochemical Therapeutic Interventions
Zahra Sebghatollahi, Ruchika Yogesh, Neelima Mahato, et al.
Antioxidants (2025) Vol. 14, Iss. 4, pp. 457-457
Open Access | Times Cited: 1
Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
Kenneth Maiese
Neural Regeneration Research (2020) Vol. 16, Iss. 3, pp. 448-448
Open Access | Times Cited: 67
The Role of Microglia in the Development of Neurodegenerative Diseases
Jae‐Won Lee, Wanjoo Chun, Hee Jae Lee, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 42
Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
Weam W. Ibrahim, Ahmed S. Kamel, Ahmed Wahid, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2505-2520
Open Access | Times Cited: 38
Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington’s disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway
Weam W. Ibrahim, Nora O. Abdel Rasheed
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1745-1758
Open Access | Times Cited: 30
Aberrant energy metabolism in Alzheimer’s disease
Linjie Yu, Jiali Jin, Yun Xu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 3, pp. 197-206
Open Access | Times Cited: 30
Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway
Marwa El-Sayed El-Shamarka, Ayman E. El-Sahar, Muhammed A. Saad, et al.
Life Sciences (2022) Vol. 300, pp. 120569-120569
Closed Access | Times Cited: 29
Crosstalk between PI3K/AKT/KLF4 signaling and microglia M1/M2 polarization as a novel mechanistic approach towards flibanserin repositioning in parkinson's disease
Nancy K. El-Deeb, Dalia M. El-Tanbouly, Mohamed Khattab, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109191-109191
Closed Access | Times Cited: 29
An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development
Shubham Upadhayay, Narhari Gangaram Yedke, Vikrant Rahi, et al.
Neurochemical Research (2023) Vol. 48, Iss. 6, pp. 1631-1647
Closed Access | Times Cited: 19
Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration
Nilima Khakha, Heena Khan, Amarjot Kaur, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 5, pp. 1152-1165
Closed Access | Times Cited: 17
The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 hub, shielding against oxidative and endoplasmic reticulum stress, and activation of p-CREB/BDNF/TrkB cascade
Noha F. Hassan, Diaa Ragab, Shaimaa G. Ibrahim, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112308-112308
Closed Access | Times Cited: 8
Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways
Marwa Mahmoud Awad, Rehab M. El‐Gohary, Sarah Ibrahim, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112110-112110
Closed Access | Times Cited: 7
Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
Lu-Lu Bu, Yi-Qi Liu, Yan Shen, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 962-978
Open Access | Times Cited: 34
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Xiaoyan Yang, Peng Feng, Rong Ji, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 445-460
Closed Access | Times Cited: 28
Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK
Mohamed Z. Habib, Mariane G. Tadros, Hadwa A. Abd-Alkhalek, et al.
European Journal of Pharmacology (2022) Vol. 927, pp. 175046-175046
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top